Mostrar el registro sencillo del ítem
dc.contributor.author
Sookoian, Silvia Cristina
dc.contributor.author
Castaño, Gustavo Osvaldo
dc.contributor.author
Pirola, Carlos Jose
dc.date.available
2025-09-29T12:15:54Z
dc.date.issued
2012-09
dc.identifier.citation
Sookoian, Silvia Cristina; Castaño, Gustavo Osvaldo; Pirola, Carlos Jose; Cardiovascular phenotype of nonalcoholic fatty liver disease: Hanging the paradigm about the role of distant toxic fat accumulation on vascular disease; John Wiley & Sons; Hepatology (Baltimore, Md.); 56; 3; 9-2012; 1185-1186
dc.identifier.issn
0270-9139
dc.identifier.uri
http://hdl.handle.net/11336/272128
dc.description.abstract
We read with great interest the article by Kim et al. about the association between nonalcoholic fatty liver disease (NAFLD) and coronary artery calcification (CAC). The authors concluded that NAFLD per se might be a risk factor for coronary artery disease (CAD) as the association was “above and beyond visceral adiposity (VAT).”1 Interestingly, the Framingham Heart Study showed that VAT, body mass index, and pericardial fat (PCF) are associated with CAC, but only PCF remains significant following risk factor adjustment, suggesting a locally toxic effect of PCF on the vasculature.2 Thus, Kim et al. still leave open a key question about whether the contribution of NAFLD to CAC is above and beyond PCF. That would be an interesting hypothesis to test, even though the current evidence linking NAFLD, carotid artery wall thickness, and plaque development strongly suggests so.3
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
John Wiley & Sons
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
FATTY LIVER
dc.subject
CARDIOVASCULAR RISK
dc.subject
NASH
dc.subject
ATHEROGENESIS
dc.subject.classification
Gastroenterología y Hepatología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Cardiovascular phenotype of nonalcoholic fatty liver disease: Hanging the paradigm about the role of distant toxic fat accumulation on vascular disease
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2025-09-01T12:45:52Z
dc.journal.volume
56
dc.journal.number
3
dc.journal.pagination
1185-1186
dc.journal.pais
Estados Unidos
dc.journal.ciudad
Nueva York
dc.description.fil
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
dc.description.fil
Fil: Castaño, Gustavo Osvaldo. Gobierno de la Ciudad de Buenos Aires. Hospital "Dr. Abel Zubizarreta"; Argentina
dc.description.fil
Fil: Pirola, Carlos Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
dc.journal.title
Hepatology (Baltimore, Md.)
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/full/10.1002/hep.25785
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/hep.25785
Archivos asociados